AnalystsRudy Li
Rudy Li's Stock Forecasts

Analyst Ranking
Top 2%
#96 out of 5266 analysts
Average Return
+104.66%
Win Rate
76%29 out of 38
Risk vs Reward
Poor
Good

Rudy Li's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Praxis Precision Medicines IncPRAX
+751.14%$38.09$324.20
2025-05-06 -
2026-05-01
Strong Buy
Alto Neuroscience IncANRO
+521.95%$4.01$24.94
2025-09-28 -
2026-05-01
Strong Buy
Praxis Precision Medicines IncPRAX
+479.34%$55.96$324.20
2025-07-28 -
2026-05-01
Strong Buy
Stoke Therapeutics IncSTOK
+275.54%$8.26$31.02
2025-03-18 -
2026-03-18
Strong Buy
Definium Therapeutics IncDFTX
+252.85%$6.15$21.70
2025-05-08 -
2026-05-01
Strong Buy

Rudy Li's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Centessa Pharmaceuticals PLCCNTA
5Buy$40.00+1.09%Initiates Coverage On
2 months ago
Alkermes PLCALKS
1Buy$45.00+34.81%Initiates Coverage On
2 months ago
Axsome Therapeutics IncAXSM
1Buy$230.00+11.36%Initiates Coverage On
2 months ago
Xenon Pharmaceuticals IncXENE
5Buy$60.00+6.89%Initiates Coverage On
2 months ago
Stoke Therapeutics IncSTOK
5Buy$40.00+20.92%Initiates Coverage On
2 months ago
Praxis Precision Medicines IncPRAX
4Buy$500.00+54.23%Initiates Coverage On
2 months ago
Neurocrine Biosciences IncNBIX
1Buy$160.00+21.41%Initiates Coverage On
2 months ago
Definium Therapeutics IncDFTX
5Buy$25.00+15.21%Initiates Coverage On
2 months ago
Acadia Pharmaceuticals IncACAD
1Buy$33.00+50.34%Initiates Coverage On
2 months ago
Bright Minds Biosciences IncDRUG
3Strong Buy$80.00N/AMaintains
4 months ago
Immunic IncIMUX
1Strong Buy$30.00+210.88%Initiates Coverage On
7 months ago
Alto Neuroscience IncANRO
1Strong Buy$15.00-39.86%Initiates Coverage On
7 months ago
Reviva Pharmaceuticals Holdings IncRVPH
1Strong Buy$40.00+4,445.45%Initiates Coverage On
7 months ago
Prothena Corp Public Ltd CoPRTA
7Strong Buy$18.00+69.17%Maintains
8 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.